✓ Възстановено плащане с кредитна карта — сигурно пазаруване чрез Privacy Shield

Terol La

✅ Relieves urinary incontinence
✅ Treats overactive bladder
✅ Намалява честото уриниране
✅ Improves bladder control
✅ Minimizes urinary urgency

Terol La contains Tolterodine Tartrate.

Медицински преглед от Morgan Ellis — Фармацевтичен изследовател · 8 години опит  · Последен преглед: май 2026 г.

Купувайте повече, спестявайте повече Цена на капсула
Изберете сила, за да видите цените на опаковките.
Шифровано плащане
Криптовалути - 10% отстъпка
Дискретна доставка по целия свят
1,400+ клиенти · 50+ държави

Quick Answer — What is Terol LA?

Terol LA съдържа tolterodine tartrate — a competitive muscarinic acetylcholine receptor antagonist used to treat overactive bladder (OAB) with urgency, frequency, and urge incontinence. Available as 2 mg and 4 mg extended-release capsules. The extended-release (LA) formulation allows once-daily dosing, with slightly less dry mouth than the immediate-release version because of smoother plasma levels. Standard dose: 4 mg once daily (or 2 mg once daily in renal/hepatic impairment, in patients on strong CYP3A4 inhibitors, or in those poorly tolerating 4 mg). Tolterodine is generally better tolerated than oxybutynin — less dry mouth, less constipation, and lower CNS penetration. Use with caution in adults aged 65+ — the 2023 American Geriatrics Society Beers Criteria classifies all anticholinergic OAB drugs as “potentially inappropriate” in older adults due to cumulative anticholinergic burden. Mirabegron (Mirago) is the preferred first-line OAB drug in this population.

Какво получавате с MedsBase: Производител, сертифициран от WHO-GMP · Дискретна опаковка · Доставка по целия свят · Над 1400 потвърдени отзива от клиенти

📦 Всяка поръчка е покрита от нашата Политика за повторна изпратка — ако вашата пратка не пристигне в рамките на 20 работни дни, ние я изпращаме отново.

🔒 Шифровано плащане · 💳 Верифициран процесор · 🚚 Доставка по целия свят · ⭐ 4.9/5 от 1,400+ клиенти

Защо да поръчвате от MedsBase

Всяка партида е закупена от СЗО-GMP сертифициран производител. Поръчките се изпращат в обикновени опаковки без маркировка от нашите партньори за изпълнение и са покрити от нашата Политика за повторна изпратка: ако пратката не пристигне в рамките на 20 работни дни, изпращаме безплатна повторна пратка, без допълнителни въпроси.

What is Terol LA?

Terol LA is a brand of tolterodine tartrate 2 mg and 4 mg extended-release capsules. Tolterodine is one of the most-prescribed antimuscarinic OAB drugs worldwide. Internationally branded as Detrol / Detrol LA (US), Detrusitol / Detrusitol XL (UK / EU). Pack sizes available at MedsBase: 30, 60, 90 or 180 tablets/capsules.

The LA (long-acting / extended-release) formulation in capsules releases tolterodine over 24 hours, allowing ежедневен прием and producing a flatter plasma-concentration curve than the immediate-release version — which translates into modestly less dry mouth and constipation.

How tolterodine works

Tolterodine is a competitive antagonist at M2 and M3 muscarinic acetylcholine receptors. Bladder M3 blockade reduces parasympathetic-driven detrusor contractions during the filling phase — decreasing urgency and incontinence episodes and increasing functional bladder capacity.

Compared to oxybutynin, tolterodine has somewhat better selectivity for bladder vs salivary-gland muscarinic receptors, lower CNS penetration, and a more favourable side-effect profile — particularly less severe dry mouth. Both are still anticholinergics with the standard class warnings about elderly use.

Tolterodine is metabolised by CYP2D6 to an active metabolite (5-hydroxymethyl tolterodine) which contributes substantially to clinical effect. About 5-10% of the population are CYP2D6 “poor metabolisers” who form less of the metabolite and need dose adjustment.

When tolterodine is used

  • Overactive bladder syndrome (OAB) with urgency, frequency, urge incontinence, nocturia — the licensed indication
  • Neurogenic detrusor overactivity — selected adult cases (multiple sclerosis, spinal cord injury)
  • Patients intolerant of oxybutynin — tolterodine is a common second-choice antimuscarinic with slightly better tolerability
  • OAB combination therapy with mirabegron — for refractory OAB symptoms in patients who tolerate but don’t fully respond to either alone

Дозиране и начин на приемане

  • Standard adult dose: 4 mg once daily, taken with water at the same time each day. Take with or without food.
  • Reduced dose 2 mg once daily for: significant renal impairment (eGFR <30), moderate hepatic impairment, concurrent strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin), or patients poorly tolerating 4 mg
  • Swallow capsule whole — do not chew, crush, or open. Doing so destroys the controlled-release matrix and releases the entire 24-hour dose at once.
  • Effect develops over 4-8 weeks. If no benefit by 8 weeks, switch to a different agent.

Странични ефекти и безопасност

  • Често (1 от 10): dry mouth (less severe than oxybutynin but still the leading reason for discontinuation), constipation, dry eyes, blurred vision, headache, dyspepsia, fatigue
  • По-рядко: drowsiness, dizziness, peripheral oedema, urinary retention or hesitancy, dry skin, weight gain
  • По-редки, но важни: confusion, hallucinations (especially in elderly), QT prolongation (caution if QT-prolonging co-medications)
  • Рядко, но сериозни: acute angle-closure glaucoma, severe constipation / paralytic ileus, urinary retention, anaphylaxis, angioedema

Anticholinergic burden & the elderly

⚠️ Anticholinergic burden in the elderly. Anticholinergic medications increase the risk of falls, cognitive decline, delirium, and dementia in older adults — particularly when stacked with other anticholinergics (diphenhydramine, hydroxyzine, amitriptyline, hyoscyamine, scopolamine, oxybutynin, tolterodine). For patients aged 65+, mirabegron (a β3-agonist) is the preferred first-line OAB drug. The 2023 American Geriatrics Society Beers Criteria classifies all anticholinergic OAB drugs as “potentially inappropriate” in older adults.

Tolterodine has somewhat lower CNS penetration than oxybutynin and is generally considered the better-tolerated of the two anticholinergic OAB drugs in older adults — but it is still classified as “potentially inappropriate” in the Beers Criteria and should be used cautiously and at the lowest effective dose. Mirabegron remains the preferred first-line OAB drug in adults aged 65+ when affordable and not contraindicated by hypertension.

Противопоказания и предупреждения

Do not take tolterodine if you have:

  • Untreated narrow-angle glaucoma
  • Urinary retention or significant bladder outlet obstruction
  • Severe gastrointestinal motility disorders (paralytic ileus, severe ulcerative colitis, toxic megacolon)
  • Миастения гравис
  • Тежко чернодробно увреждане
  • Hypersensitivity to tolterodine or fesoterodine (its prodrug)

Използвайте с предпазливост при: elderly age (see above), benign prostatic hyperplasia (urinary retention risk), reflux oesophagitis, autonomic neuropathy, congenital or acquired QT prolongation, coronary artery disease.

Взаимодействия с лекарства

  • Силни CYP3A4 инхибитори (ketoconazole, itraconazole, ritonavir, clarithromycin, indinavir) — sharply increase tolterodine levels; reduce dose to 1 mg BD (IR) or 2 mg OD (LA)
  • Other anticholinergics — additive effects; minimise stacking (diphenhydramine, hydroxyzine, amitriptyline, paroxetine, quetiapine, hyoscyamine, oxybutynin)
  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine for dementia) — opposing mechanisms; co-prescribing both is irrational
  • Лекарства, удължаващи QT интервала (Клас Ia/III антиаритмици, някои антипсихотици, хинолонови антибиотици) — теоретичен адитивен риск
  • CYP2D6 substrate medications — tolterodine is metabolised by CYP2D6, so poor metabolisers (5-10% of population) have higher exposure

How tolterodine compares

ЛекарствоХарактерна особеност
OxybutyninOlder, cheaper; highest dry mouth + cognitive risk
Tolterodine IR / LABetter tolerated than oxybutynin; LA gives once-daily dosing
Solifenacin / darifenacinMore M3-selective; slightly less dry mouth
Mirabegronβ3 agonist — preferred first-line in 65+; no anticholinergic burden
Flavoxate (Urispas)Antispasmodic; useful for urinary spasm post-procedure

Съхранение и срок на годност

Store Terol LA below 25°C in the original blister pack. Protect from moisture and light. Keep out of reach of children. Do not use after the expiry date.

Често задавани въпроси

What’s the difference between Terol LA and Roliten (immediate-release)?

Same active ingredient (tolterodine tartrate), different release profile. Roliten 1 mg twice daily uses immediate-release tablets — cheaper, more flexible dose adjustment, but plasma peaks-and-troughs cause more variable side effects. Terol LA 4 mg once daily uses an extended-release capsule — flatter plasma curve translates into modestly less dry mouth, simpler regimen (better adherence). Choose LA for convenience and tolerability; choose IR if you need finer dose titration.

Why does tolterodine cause dry mouth?

Tolterodine blocks the M3 muscarinic receptors that drive saliva production — the same receptor it blocks in the bladder. Side-effect mitigation: sugar-free chewing gum, frequent sips of water, saliva substitute (Biotene). If dry mouth is intolerable, mirabegron (Mirago) avoids the antimuscarinic mechanism altogether.

How long until tolterodine works?

Initial improvement in urgency and frequency is typically noticeable within 1-2 weeks; full effect over 4-8 weeks. If no benefit by 8 weeks at the maximum tolerated dose, switching to a different OAB drug (mirabegron, solifenacin) is reasonable.

Can I take tolterodine if I am over 65?

The 2023 American Geriatrics Society Beers Criteria classifies all anticholinergic OAB drugs as “potentially inappropriate” in older adults. Tolterodine is somewhat better tolerated than oxybutynin but still carries the anticholinergic burden risk — falls, cognitive slowing, possible long-term dementia association. Discuss mirabegron first with your doctor; it has equivalent efficacy without these risks.

Can I take tolterodine with mirabegron?

Yes — combination therapy with a low-dose anticholinergic plus mirabegron is well-evidenced for refractory OAB symptoms (BESIDE-style data). Monitor for urinary retention, particularly in men with bladder outlet obstruction.

Will tolterodine affect my driving or work?

Drowsiness, dizziness, and blurred vision can affect driving or operating machinery. Avoid until you know how the medication affects you. Effects typically settle after the first 1-2 weeks.

Where can I order Terol LA online?

You can order Terol LA from MedsBase in standard pack sizes. Orders ship worldwide with discreet packaging. Tolterodine is specialist-supervised worldwide.

⚕ Медицинско известие. Тази страница е само за информационни цели и не замества медицинските съвети на квалифициран здравен специалист. Винаги консултирайте се с лекаря си или фармацевт преди да започнете, промените или спрете лечение за уринарни или простатни симптоми — те могат да бъдат ранни признаци на състояния (уринарна инфекция, рак на простатата, камъни в пикочния мехур), които изискват диагноза и целево лечение, а не само симптоматично облекчение. MedsBase не предоставя диагнози, рецепти или клинични препоръки.

Свързани алтернативи

Други продукти в Общо здраве които клиентите също разглеждат:

Още опции в Пикочен мехур/Простата

Класирани според скорошния обем на поръчки в MedsBase — какво избират други клиенти в тази категория.

Сила

2 mg, 4 mg

Количество

30 капсули, 60 капсули, 90 капсули, 180 капсули

Отзиви

Все още няма отзиви

Добавете отзив
Terol La Terol La
Рейтинг*
0/5
* Рейтингът е задължителен
* Отговорът е задължителен
Вашият отзив
* Отзивът е задължителен
Име
* Името е задължително
Добавете снимки или видео към вашия отзив

Въпроси и отговори

Задайте въпрос
Terol La Terol La
Вашият въпрос
* Въпросът е задължителен
Име
* Името е задължително
Все още няма въпроси